Cardiac Resynchronization in Chronic Heart Failure
William T. Abraham, Westby G. Fisher, Andrew L. Smith, David B. DeLurgio, Evan Loh, Dusan Z. Kocovic, Milton Packer, Alfredo L. Clavell, David L. Hayes, Myrvin Ellestad, Robin J. Trupp, Jackie Underwood, Peggy McAtee, John C. Messenger
New England Journal of Medicine · 2002 · 4,880 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Abraham, W. T., Fisher, W. G., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., Ellestad, M., Trupp, R. J., Underwood, J., Pickering, F., Truex, C., McAtee, P., & Messenger, J. C. (2002). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346(24), 1845–1853. https://doi.org/10.1056/nejmoa013168
In text: (Abraham et al., 2002)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
BACKGROUND: Previous studies have suggested that cardiac resynchronization achieved through atrial-synchronized biventricular pacing produces clinical benefits in patients with heart failure who have an intraventricular conduction delay. We conducted a double-blind trial to evaluate this therapeutic approach. METHODS: Four hundred fifty-three patients with moderate-to-severe symptoms of heart failure associated with an ejection fraction of 35 percent or less and a QRS interval of 130 msec or more were randomly assigned to a cardiac-resynchronization group (228 patients) or to a control group (225 patients) for six months, while conventional therapy for heart failure was maintained. The primary end points were the New York Heart Association functional class, quality of life, and the distance walked in six minutes. RESULTS: As compared with the control group, patients assigned to cardiac resynchronization experienced an improvement in the distance walked in six minutes (+39 vs. +10 m, P=0.005), functional class (P<0.001), quality of life (-18.0 vs. -9.0 points, P= 0.001), time on the treadmill during exercise testing (+81 vs. +19 sec, P=0.001), and ejection fraction (+4.6 percent vs. -0.2 percent, P<0.001). In addition, fewer patients in the group assigned to cardiac resynchronization than control patients required hospitalization (8 percent vs. 15 percent) or intravenous medications (7 percent vs. 15 percent) for the treatment of heart failure (P<0.05 for both comparisons). Implantation of the device was unsuccessful in 8 percent of patients and was complicated by refractory hypotension, bradycardia, or asystole in four patients (two of whom died) and by perforation of the coronary sinus requiring pericardiocentesis in two others. CONCLUSIONS: Cardiac resynchronization results in significant clinical improvement in patients who have moderate-to-severe heart failure and an intraventricular conduction delay.
Related papers
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction2002
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure2005
- Impact of Atrial Fibrillation on the Risk of Death1998
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia1996
- Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies2016
Metadata from OpenAlex (CC0). Citations are generated from the published record.